Iovance Biotherapeutics, Inc. (IOVA) Balance Sheet
As of 2026-06-30 (10-Q), Iovance Biotherapeutics, Inc. (IOVA) reported total assets of $915.5M, total liabilities of $179.5M and shareholders' equity of $736.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $110.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IOVAIovance Biotherapeutics, Inc.Follow IOVA — free
—
Price chart with a free account
- Market cap
- 6.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.5 | 0.0 | 19.7 | 44.9 | 33.6 | 106.7 | 145.4 | 82.2 | 14.0 | 67.3 | 78.2 | 231.7 | 114.9 | 115.7 | 163.1 | 110.8 | |
| Short-term investments | — | — | — | 0.0 | 70.1 | 59.8 | 0.0 | 386.4 | 293.1 | 562.1 | 426.2 | 240.1 | 165.0 | 208.1 | 133.9 | 186.9 | |
| Receivables | — | — | — | — | — | — | — | — | — | — | — | — | 0.2 | 69.3 | 82.4 | 102.1 | |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | 10.4 | 51.5 | 51.7 | 55.6 | |
| Current assets | 0.5 | 0.0 | 19.8 | 45.0 | 104.0 | 169.5 | 149.3 | 475.4 | 316.5 | 636.1 | 508.0 | 479.1 | 307.8 | 457.0 | 442.7 | 464.3 | |
| Total assets | 0.6 | 0.0 | 19.9 | 46.5 | 105.7 | 171.9 | 155.4 | 480.8 | 344.7 | 768.5 | 777.3 | 664.0 | 780.4 | 910.4 | 913.2 | 915.5 | |
| Current liabilities | 13.3 | 11.3 | 2.3 | 1.7 | 1.6 | 5.0 | 9.6 | 14.4 | 39.1 | 54.9 | 89.2 | 91.5 | 110.3 | 122.3 | 138.4 | 106.8 | |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | 1.0 | 1.0 | 1.0 | 1.0 | — | — | |
| Short-term debt | 5.0 | 5.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | — | — | — | — | — | — | 9.9 | 14.6 | 45.7 | 112.0 | 155.7 | 164.3 | 195.7 | 200.0 | 214.6 | 179.5 | |
| Shareholders' equity | -12.8 | -11.3 | 17.6 | 44.8 | 104.0 | 166.9 | 145.5 | 466.2 | 299.0 | 656.5 | 621.7 | 499.6 | 584.6 | 710.4 | 698.6 | 736.0 |
USD millions · SEC XBRL
Iovance Biotherapeutics, Inc. — questions
- How much cash does Iovance Biotherapeutics, Inc. have?
- $110.8M in cash and cash equivalents as of 2026-06-30.
- What are Iovance Biotherapeutics, Inc.'s total assets?
- $915.5M as of 2026-06-30.
- What is Iovance Biotherapeutics, Inc.'s shareholders' equity?
- $736.0M as of 2026-06-30.
Every figure on this page comes from Iovance Biotherapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.